These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12030207)

  • 1. Antiretroviral toxicities take center stage at the 9th CROI (Conference on Retroviruses and Opportunistic Infections).
    Lucas GM
    Hopkins HIV Rep; 2002 Mar; 14(2):1, 4, 9. PubMed ID: 12030207
    [No Abstract]   [Full Text] [Related]  

  • 2. Report from Boston: the 12th Conference on Retroviruses and Opportunistic Infections (CROI). February 22-25, 2005. Complications/toxicity of HIV therapy.
    Moore RD; Cofrancesco J
    HIV Clin Trials; 2005; 6(4):229-34. PubMed ID: 16214738
    [No Abstract]   [Full Text] [Related]  

  • 3. Report from Boston: the 12th Conference on Retroviruses and Opportunistic Infections (CROI). Complications/toxicity of HIV therapy.
    Moore RD; Confrancesco J
    Hopkins HIV Rep; 2005 May; 17(3):1-5, 9. PubMed ID: 16419310
    [No Abstract]   [Full Text] [Related]  

  • 4. Mitochondrial toxicity and lactic acidosis.
    Proj Inf Perspect; 2000 Mar; (29):10-1. PubMed ID: 12772662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic complications of HIV therapy.
    Chow DC; Day LJ; Souza SA; Shikuma CM
    IAPAC Mon; 2006 Sep; 12(9):302-17. PubMed ID: 17378067
    [No Abstract]   [Full Text] [Related]  

  • 6. 'Fine tuning' HIV therapy. Report on the 9th Conference on Retroviruses and Opportunistic Infections.
    Linde M
    Posit Living; 2002; 11(3):8-9, 16, 44. PubMed ID: 12035759
    [No Abstract]   [Full Text] [Related]  

  • 7. 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. San Diego, California, USA 22-25 September 2002.
    Nolan D; Christiansen F
    Expert Opin Drug Saf; 2003 Jan; 2(1):95-101. PubMed ID: 12904128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A report from the Conference on Retroviruses and Opportunistic Infections (CROI) 2015 (February 23-26--Seattle, Washington, USA).
    Rabasseda X
    Drugs Today (Barc); 2015 Mar; 51(3):209-16. PubMed ID: 25876564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on mitochondrial toxicity of antiretrovirals and its link to lipodystrophy.
    McComsey G
    AIDS Rev; 2002; 4(3):140-7. PubMed ID: 12416448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update from the 8th CROI: adverse effects of HAART and structured treatment interruption.
    Bartlett JG
    Hopkins HIV Rep; 2001 May; 13(3):8-9. PubMed ID: 12085827
    [No Abstract]   [Full Text] [Related]  

  • 11. Lactic acidosis in HIV infected children due to antiretroviral therapy.
    Shah I
    Indian Pediatr; 2005 Oct; 42(10):1051-2. PubMed ID: 16269849
    [No Abstract]   [Full Text] [Related]  

  • 12. [Toxicity of antiretroviral drugs].
    Lallemand F
    Presse Med; 1999 Nov; 28 Suppl 3():35-6. PubMed ID: 10605467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting lactic acidosis in an HIV-1 infected pregnant woman on antiretroviral therapy.
    Mendes N; Aboím L; Borges A; Guerreiro C; Castelo-Branco C
    J Obstet Gynaecol; 2013 Apr; 33(3):310-2. PubMed ID: 23550869
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV-associated lipodystrophy, metabolic complications, and antiretroviral toxicities.
    Moyle G; Carr A
    HIV Clin Trials; 2002; 3(1):89-98. PubMed ID: 11894812
    [No Abstract]   [Full Text] [Related]  

  • 15. Nucleoside analogues toxicities related to mitochondrial dysfunction: focus on HIV-infected children.
    Viganò A; Giacomet V
    Antivir Ther; 2005; 10 Suppl 2():M53-64. PubMed ID: 16152706
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for mitochondrial toxicity: lactic acidosis as proof of concept.
    Brinkman K
    J HIV Ther; 2001 Mar; 6(1):13-6. PubMed ID: 11501196
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.
    Leonard EG; McComsey GA
    Infect Dis Clin North Am; 2005 Sep; 19(3):713-29. PubMed ID: 16102657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus infection with human granulocytic ehrlichiosis complicated by symptomatic lactic acidosis.
    Springer SA; Altice FL
    Clin Infect Dis; 2003 Jun; 36(12):e162-4. PubMed ID: 12802782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly active antiretroviral HIV therapy-associated fatal lactic acidosis: quantitative and qualitative mitochondrial DNA lesions with mitochondrial dysfunction in multiple organs.
    Thoden J; Lebrecht D; Venhoff N; Neumann J; Müller K; Walker UA
    AIDS; 2008 May; 22(9):1093-4. PubMed ID: 18520357
    [No Abstract]   [Full Text] [Related]  

  • 20. Evolving toxicities associated with anti-HIV therapies.
    Bean P
    Am Clin Lab; 2002 May; 21(4):12-5. PubMed ID: 12087632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.